Text

Microbiota linked to susceptibility to necrotizing enterocolitis in preemies

The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.

Microbiome’s implications in recurrent pregnancy loss

A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

Study sheds light on microbial diversity and antibiotic resistance

The findings improve our understanding of the genetic complexity of the human gut microbiota and its implications for health.

Dietary components may affect health differently based on gut microbiota

The findings highlight the complex interactions between some dietary compounds and the gut microbiota, suggesting that microbial variations can impact health in different ways.

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

How the gut microbiota protects a newborn’s health

The findings highlight the importance of the gut microbiota in gut development and immunity, and they provide insights into how microbiota-based interventions could prevent serious conditions such as NEC.

How gut bacteria communities resist drugs

Many common drugs — including antibiotics — can inhibit the growth of gut bacteria and alter their function.

Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th Session without Adopting Probiotic Guidelines

In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top